CHS Inc.
Consumer DefensiveNASDAQ:CHSCL · NASDAQ Global Select
+$0.05 today
Vol 0.01M · Avg 0.02M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$35.6B of revenue converted into $542.3M of net income for the selected period. Gross margin is 2.9% and net margin is 1.5%, showing how much revenue survives after costs and taxes. EPS is $0.00, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.5B -9.7% | $39.3B -13.9% | $45.6B -4.6% | $47.8B +24.3% | $38.4B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $34.3B -8.5% | $37.5B -12.4% | $42.8B -5.1% | $45.1B +23.3% | $36.6B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.1B -35.1% | $1.8B -37.1% | $2.8B +3.4% | $2.7B +43.5% | $1.9B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 3.2% -1.3pp | 4.5% -1.6pp | 6.1% +0.5pp | 5.6% +0.8pp | 4.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.0B -9.4% | $1.2B +11.8% | $1.0B +3.4% | $998.4M +33.7% | $746.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.0B -10.4% | $1.2B +13.0% | $1.0B +3.4% | $998.4M +33.7% | $746.7M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $651.4M +35.2% | $481.7M +3.7% | $464.6M +0.6% | $462.0M +0.1% | $461.7M | $374.2M | $1.2B | $631.8M |
| EBITDA | $1.4B -16.1% | $1.7B -35.5% | $2.6B +9.4% | $2.4B +120.6% | $1.1B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 4.0% -0.3pp | 4.3% -1.4pp | 5.7% +0.7pp | 5.0% +2.2pp | 2.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | $90.8M -84.5% | $584.4M -66.6% | $1.8B +3.3% | $1.7B +50.0% | $1.1B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 0.3% -1.2pp | 1.5% -2.4pp | 3.8% +0.3pp | 3.5% +0.6pp | 2.9% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 -100.0% | $114.2M +9.2% | $104.6M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $146.1M +40.4% | $104.1M -24.3% | $137.4M +14.3% | $120.3M +6.8% | $112.6M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $524.0M +2.1% | $513.4M +99.7% | $257.1M +121.7% | $116.0M +118.9% | -$614.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $614.8M -44.0% | $1.1B -45.3% | $2.0B +10.9% | $1.8B +251.2% | $515.3M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 1.7% -1.1pp | 2.8% -1.6pp | 4.4% +0.6pp | 3.8% +2.4pp | 1.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $16.8M +444.4% | -$4.9M -104.5% | $107.7M -18.5% | $132.1M +445.4% | -$38.2M | $1.3B | -$1.6B | $745.2M |
| Net Income | $597.9M -45.8% | $1.1B -42.0% | $1.9B +13.2% | $1.7B +203.1% | $554.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | 1.7% -1.1pp | 2.8% -1.4pp | 4.2% +0.7pp | 3.5% +2.1pp | 1.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $0 | $0 | $0 | $0 | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $0 | $0 | $0 | $0 | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $0 | $0 | $0 | $0 | $0 | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $0 | $0 | $0 | $0 | $0 | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
G. Willi-Food International Ltd.
NASDAQ:WILC
$480.46M
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
NYSE:LND
$372.56M
Nature's Sunshine Products, Inc.
NASDAQ:NATR
$360.67M
B&G Foods, Inc.
NYSE:BGS
$327.10M
Alico, Inc.
NASDAQ:ALCO
$302.81M
Forafric Global PLC
NASDAQ:AFRI
$269.64M
Limoneira Company
NASDAQ:LMNR
$234.99M
Village Farms International, Inc.
NASDAQ:VFF
$232.01M
BRC Inc.
NYSE:BRCC
$159.13M
Solesence, Inc. Common Stock
NASDAQ:SLSN
$93.94M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CHSCL generate?
CHS Inc. (CHSCL) reported $35.46B of revenue in fiscal 2025.
Is CHSCL profitable?
CHS Inc. (CHSCL) reported $597.92M of net income, with a net margin of 1.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.